Cited by 264Liver physiology and pathologyDrug-Induced Hepatotoxicity and ProtectionTelomeres, Telomerase, and Senescence

TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence

Open access
Bird, Thomas G., Müller, Miryam, Boulter, Luke, Vincent, David F., Ridgway, Rachel A., Lopez-Guadamillas, Elena, Lu, Wei-Yu, Jamieson, Thomas +26 more·2018·Science Translational Medicine

Abstract

Inhibiting acute injury–induced senescence mediated by TGFβ signaling in regenerative epithelium improves liver regeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aan1230

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TGF-β improves liver regeneration after injury by blocking paracrine senescence in neighbouring uninjured hepatocytes.

    “Similarly, transforming growth factor-β improves liver regeneration on injury by blocking paracrine senescence in neighbouring uninjured hepatocytes188.”

    From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [188]

    The Introduction says macrophage-derived TGFβ drives the spread of senescence between hepatocytes. The Results section on TGFβR1 inhibition reports that blocking TGFβ signaling—not TGFβ itself—reduced hepatocellular senescence and improved regeneration after acute liver injury. Page numbers are not provided in our copy. (LLM, conf=0.94)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Paracrine senescence contributes to liver dysfunction upon acetaminophen overdose.

    “While the role of paracrine senescence in cancer is yet undefined, it has been found to contribute to liver dysfunction upon acetaminophen overdose (Bird et al. 2018).”

    From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Bird et al. 2018

  • Individual SASP components, such as TGF-β, might be pinpointed as disease drivers and targeting them specifically might be appropriate.

    “Other times, individual SASP components, such as TGF-β, might be pinpointed as disease drivers and targeting them specifically might be appropriate (Bird et al. 2018).”

    From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Bird et al. 2018

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [51]Lu WY Bird TG Boulter L Tsuchiya A Cole AM Hay T Guest RV Wojtacha D Man TY Mackinnon A Ridgway RA Hepatic progenitor cells of biliary origin with liver repopulation capacity Nature cell biology 2015 PMC4612439 26192438

Cited by

Sorted by citations

Authors
Bird, T. G., Müller, M., Boulter, L., Vincent, D. F., Ridgway, R. A., Lopez-Guadamillas, E., Lu, W.-Y., Jamieson, T., Govaere, O., Campbell, A. D., Ferreira-Gonzalez, S., Cole, A. M., Hay, T., Simpson, K. J., Clark, W., Hedley, A., Clarke, M., Gentaz, P., Nixon, C., Bryce, S., Kiourtis, C., Sprangers, J., Nibbs, R. J. B., Van Rooijen, N., Bartholin, L., McGreal, S. R., Apte, U., Barry, S. T., Iredale, J. P., Clarke, A. R., Serrano, M., Roskams, T. A., Sansom, O. J., & Forbes, S. J.
Affiliations
  • MRC Centre for Regenerative Medicine (GB)
  • Cancer Research UK Scotland Institute (GB)
  • Spanish National Cancer Research Centre (ES)
  • Universitair Ziekenhuis Leuven (BE)
  • Medical Research Council (MRC) Centre for Regenerative Medicine, University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
  • Cardiff University (GB)
  • University of Glasgow (GB)
  • Vrije Universiteit Medical Center, Department of Molecular Cell Biology, Van der Boechorststraat 7, 1081 BT Amsterdam, Netherlands.
  • Lyon 1 Université (FR)
  • University of Kansas Medical Center (US)
  • AstraZeneca (United Kingdom) (GB)
  • University of Bristol (GB)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author
  • Bird, Thomas G.
  • Clarke, Alan R.
Venue
Science Translational Medicine
Published
2018-08-15
Volume
10
Issue
454
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2887276938
Cited by
261
References
61
Citations by year
2026: 16 · 2025: 34 · 2024: 47 · 2023: 42 · 2022: 31 · 2021: 28 · 2020: 37 · 2019: 24 · 2018: 2
FWCI
14.26
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, other-oa)
  • Bristol Research (University of Bristol) (publishedVersion, other-oa)
  • Explore Bristol Research (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Lirias (KU Leuven) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • National Institutes of Health (R01 DK98414)
  • Wellcome Trust (107492Z, 081604AIA)
  • Medical Research Council (G1000868, G0900992)
  • Cancer Research UK (2016-CRUK core running, A12481)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
Keywords
acute liver injury, liver regeneration, hepatocyte senescence, paracrine senescence, TGF-β1, acetaminophen toxicity, p21, macrophages, hepatocyte proliferation, acute liver failure
MeSH terms
Animals, Disease Models, Animal, Humans, Liver, Liver Regeneration, Macrophages, Male, Mice, Inbred C57BL, Necrosis, Signal Transduction, Transforming Growth Factor beta, Cellular Senescence, Paracrine Communication, Hepatocytes, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review